Litazolidone

利他唑酮

Report date: 2022/03/15 14:52:21
NME

Base Information

Drug NameLitazolidone
Drug Alias NameLT-01
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Oxazolidinone antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsHospital-acquired pneumoniaCommunity Acquired PneumoniaGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSichuan Saizhuo Pharmacy Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShandong Jincheng Pharmaceutical Co LtdSichuan Saizhuo Pharmacy Co Ltd
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaCommunity Acquired Pneumonia
Inactive IndicationsGram-Positive Bacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A